The miniature models have the potential to significantly speed up vaccine development, advance cancer treatment research, and enhance health outcomes for a wide range of diseases. To gain deeper ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study.

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).